- About Us
- Contact Us
Xcel™ is the optimal biomarker discovery platform. The Xcel™ array contains 92,000 transcripts, including a significant amount of proprietary information and is optimised for use with Formalin Fixed Paraffin Embedded (FFPE) tissue.
Xcel™ array is a high density transcriptome based microarray based on the industry standard Affymetrix GeneChip® platform. The content of the array has been derived from high quality proprietary sequence data in addition to mining public gene expression and sequence databases. The design methodologies of the array are based on the validated methods derived for Almac’s range of cancer DSA® (Disease Specific Arrays).
The substantial content on Almac’s Xcel™ array makes it the ideal platform for research in cross-disease areas, a notable advantage to pharmaceutical companies.
Cancer DSA ®
Each Cancer DSA ® research tool is designed around an individual disease and tissue specific transcriptome and as a result contains significant, additional and relevant information.
The range has been developed by a process of high throughput sequencing, gene expression profiling and intensive bioinformatics analysis, in order to characterise the transcriptome of the disease and include significant additional relevant data not available from any other microarray.
For full details on contents of each DSA: